LumaCyte

ASGCT 2025 is on the horizon, and LumaCyte is thrilled to participate and collaborate with the some of the brightest minds in gene and cell therapy. By leveraging our cutting-edge Label-free Cellular Process Analytical Technology (PAT), we’re committed to doing our part to advance manufacturing success and drive improvements in both production yields and therapeutic outcomes. Register today to meet the LumaCyte team and join the community that is focused on the future, where advanced therapies are accessible by all who need them! For event info, visit: annualmeeting.asgct.org! #InnovatewithLumaCyte #LaserForceCytology #GeneandCellTherapy #ASGCT2025 #TherapeuticBreakthroughs #MedicalAdvances #GeneTherapyPioneers #PATAnalytics #ImprovedHealthcare #CellularAnalytics

Are you driven by opportunities to breakthrough status quo barriers? Do you believe advanced analytics have the ability to revolutionize the future of bioprocess and manufacturing outcomes? Are you located in Boston? If so, than LumaCyte is looking for YOU! Join LumaCyte as a Field Application Scientist (FAS) and become part of a team pushing the boundaries of innovation and scientific excellence. Based in the dynamic city of Boston, Massachusetts, you’ll play a pivotal role in redefining the industry through cutting-edge analytics. Don’t wait to make your mark. Take the leap toward an extraordinary career—apply today at HR@lumacyte.com! lumacyte.com/careers/ #JobOpportunity #FieldApplicationScientist #AdvancedAnalytics #ScienceCareers #LumaCyte #Innovation #BostonJobs #HiringNow #Bioprocess #CareerGrowth #ScientificExcellence @ISCT @ASGCTherapy

Beyond Viability: Healthier Cells, Better Therapies. What if cell health wasn’t just viable, but optimal? Discover how advanced technologies are reshaping cell therapy by redefining viability. Dive into the future of healthier, more robust cells: lumacyte.com/applications/c… #CellTherapy #Innovation #CellHealth #FutureOfMedicine #BiotechBreakthrough

Don't Miss Out! Join Renee A. Hart from LumaCyte on May 8th at 5 PM for an engaging panel discussion at the ISCT Annual Meeting:"Can Cellular Starting Material Predict Therapeutic Outcomes." Be part of the conversation as industry leaders dive into this pioneering topic and share their insights. Collaborate with delegates and experts to address real-world challenges in the CGT spectrum, turning ideas into actionable solutions. Sign up today: isctglobal.org/annual-meeting… #ISCT2025 #CellularTherapeutics #CGTInnovation #LifeSciences #PanelDiscussion #ScientificInsights #TherapeuticOutcomes #BiotechConversations #CollaborativeSolutions #HealthcareInnovation

Revolutionizing Cell Health Monitoring in Biomanufacturing Learn how Laser Force Cytology™ (LFC) is transforming bioprocessing! Our latest technote explores how the Radiance® instrument provides real-time, label-free insights into cellular health under oxidative stress—offering a groundbreaking alternative to traditional viability assays. Unlock the potential of LFC to optimize processes, reduce failures, and improve outcomes. Read the full technote now and stay at the forefront of biomanufacturing innovation! lumacyte.com/resources/tech… #Biomanufacturing #CellTherapeutics #ProcessInnovation #LaserForceCytology #LumaCyte

Advancing Vaccine Production: Key Insights from Our Webinar Scientists from Thermo Fisher Scientific and LumaCyte achieved a 10-fold increase in viral titer using the Gibco™ Adherent Kidney Media Panel, designed to support Vero cells in vaccine and viral vector applications. The case study demonstrates how LumaCyte's Laser Force Cytology™ (LFC™) technology enables real-time optimization, accelerating process development and improving manufacturing efficiency. The tailored media panel simplifies bioprocessing with six ready-to-use, serum-free, animal origin–free formulations, offering users the ability to compare media, identify process improvements, and enhance productivity while reducing time-to-market. Learn more about achieving significant increases in viral titer and accelerating time-to-market! lumacyte.com/resources/inte… #ViralVaccine #BioprocessingInnovation #CellTherapeutics #LaserForceCytology #ThermoFisherScientific #LumaCyte

Unlock the Power of Precision Analytics with Radiance by LumaCyte! Experience unparalleled accuracy and efficiency in your biomanufacturing processes with LumaCyte's advanced precision analytics and Radiance platform. Our cutting-edge technology ensures real-time monitoring and optimization, driving consistent and high-quality production. Discover more: lumacyte.com/products/radia… #PrecisionAnalytics #Radiance #Biomanufacturing #RealTimeMonitoring #TechInnovation #Biotech #LumaCyte #AdvancedAnalytics #QualityControl #Efficiency #Innovation

Transform Your Biomanufacturing with Label-Free Cellular PAT Analytics! Achieve heightened production consistency and maximize product yields through cutting-edge real-time monitoring. Ready to elevate your processes? Learn more here: lumacyte.com/applications/b… #Biomanufacturing #PATAnalytics #RealTimeMonitoring #ProductionConsistency #Innovation #Biotech #CellularAnalytics #Efficiency #TechAdvancement #Lumacyte

Revolutionize CAR-T Therapy Development and Manufacturing with LumaCyte's Predictive Donor & Patient Screening Service LumaCyte's Predictive Donor Screening Service utilizes Laser Force Cytology advanced analytics to characterize donor cells in real-time, enhancing consistency and reducing manufacturing risks through its multiparametric predictive modeling capability. This innovative approach ensures high-quality materials are selected from the very start, improving manufacturing success and opening the door to commercial production scale. lumacyte.com/applications/l… #CAR_TTherapy #LumaCyte #PredictiveScreening #DonorScreening #AdvancedAnalytics #LaserForceCytology #ManufacturingSuccess #CommercialProduction #InnovativeApproach #BiotechSolutions

Navigating the Future: Key Take Aways from Phacilitate ATW and CASSS WCBP The Phacilitate Advanced Therapies Week (ATW) held January 20-23, 2025, in Dallas, Texas, and the CASSS Well Characterized Bioprocess (WCBP) held January 28-30, 2025, in Washington, D.C. highlighted the critical need for advanced cellular process analytical technology (PAT) analytics in driving innovation and quality across complex biopharmaceutical manufacturing. These events brought together industry thought leaders to share insights, discuss emerging trends, and foster collaborations that will shape the future of cell and gene therapies. By emphasizing the need for sophisticated PAT tools, the conferences underscored the industry's commitment to improving process control, product consistency, and patient outcomes. Read more about the future of ATMP bioprocess and manufacturing in our January conference recap blog post. Thank you to everyone who attended and contributed to these successful events. Stay tuned for more exciting updates and advancements from LumaCyte in 2025! lumacyte.com/uncategorized/… #PhacilitateATW #CASSSWCBP #CellTherapies #GeneTherapies #Biopharma #PATAnalytics #AdvancedTherapies #InnovationInBiotech #ManufacturingSuccess #LumaCyteEvents #LFC #LaserForceCytology

Discover the future of precision analytics with LumaCyte at the WCBP 2025 conference on January 28-30, 2025 in Washington, DC. Join us for an in-person seminar titled "Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): The Future of Precision Analytics for Improved Manufacturing Success," presented by Colin Hebert, LumaCyte, SVP Scientific and Business Operations. This insightful session will take place on Tuesday, January 28, 2025, from 12:25 PM to 1:25 PM. Don’t miss this opportunity to learn about groundbreaking advancements in cell characterization and the predictive power of Laser Force Cytology. #WCBP2025 #PrecisionAnalytics #LumaCyte #LaserForceCytology #BiotechInnovation #HealthcareAdvancement #IndustryLeaders #CellCharacterization #ReneeHart #ScientificConference

Join the LumaCyte Team at Advanced Therapies Week next week in Dallas, Texas. Discover groundbreaking innovations and network with industry leaders at the premier event for advanced therapies. Don’t miss your chance to explore cutting-edge research, gain insights from the brightest minds, and shape the future of healthcare. Visit us at Booth 448. Schedule a meeting with LumaCyte. lumacyte.com/schedule-a-mee… #AdvancedTherapiesWeek #HealthcareInnovation #LumaCyte #FutureOfMedicine #Biotech #MedicalResearch #CuttingEdgeScience #Dallas2025 #AdvancedTherapies

We wish everyone a very bright and prosperous 2025. May this be the year our industry accelerates and achieves milestone level scientific advancements that drive significant growth across the sector. At LumaCyte we are proud to stand beside you lighting the path and delivering novel insights through our advanced precision cellular analytics. Together, we are transforming the status quo, illuminating therapeutic breakthroughs and cures for patients who are waiting. May the New Year bring you much health, prosperity and success in 2025. Happy New Year!

As Christmas approaches, we celebrate the joy of discovery at LumaCyte. Each cell we analyze brings new insights and innovations, lighting up the world of analytics. Merry Christmas & Happy Holidays!

Event Recap: 6th Annual Cell Therapy Analytical Development Summit What an incredible gathering at the Cell Therapy Analytical Development Summit! We were honored to have LumaCyte's President and CBO, Renee A. Hart, join industry leaders Ramon Mendoza, Alexandre Ambrogelly, and Stephan O. Krause, PhD, for the Industry Leaders’ Fireside Chat. Their discussion on "Pioneering Analytical Frontiers to Overcome the Complexities of Cell Therapy Products" offered invaluable insights from some of the foremost analytical minds in the field. We were also thrilled to see Colin Hebert, LumaCyte’s Senior Vice President of Scientific & Business Operations, present at the summit. His session on "Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): Predictive Insights into CAR T Donor Variability" was standing room only and showcased the transformative potential of LFC as a quantitative label-free precision PAT. Colin's insights on the correlation of CAR T potency with donor cellular starting material and T-cell activation road mapping illustrated the powerful impact predictive analytics can bring to advanced therapy manufacturing. Additionally, Laura Pierce from NIST gave a fantastic talk on the importance of precise cell viable state analytics highlighting some work that she and her team have been doing at NIST with Laser Force Cytology. Thank you to everyone who attended and contributed to the success of this event. Stay tuned for more exciting updates and advancements from LumaCyte! #CellTherapy #AnalyticalDevelopment #LumaCyte #Innovation #Healthcare #SummitRecap

Thank you Chris Spivey and BioPharm International for the invitation for LumaCyte’s CEO and CSO, Sean Hart, PhD to participate in this industry expert panel, Fixing the Potholes in CGT Manufacturing. Listen in to hear Dr. Peter Marks, from CBER FDA, Fabian Gerlinghaus, from Cellares, Fyodor Urnov from Innovative Genomics Institute, share their perspectives and expertise on addressing the complexities associated with advanced therapy manufacturing. Precision manufacturing is paving the way for the future of life-saving cell and gene therapies, ensuring that every treatment is consistent and of the highest quality. Forward-thinking regulators are pivotal in encouraging the industry to embrace innovative solutions and overcome traditional process and analytical barriers. Analytics and automation are pivotal in driving us towards advanced manufacturing processes, seamlessly working together to enable commercial scale and drive improvements in production yields. The power of prescriptive and predictive analytics through a robust parametric approach is opening the door to adaptive manufacturing processes with improved success rates and outcomes. Read more: biopharminternational.com/view/standardi… #Biopharmaceuticals #Biopharma #QualityStandards #Innovation #Healthcare #LumaCyte #CGTtherapies #CART #CellAndGeneTherapies

In a recent BiotechTV interview, Colin Hebert, Senior Vice President of Scientific & Business Operations at LumaCyte, discusses how Radiance's platform technology utilizes lasers for single cell analysis. Explore the groundbreaking impact of LumaCyte's Laser Force Cytology™ technology on research and biomanufacturing procedures. #LumaCyte #SingleCellAnalysis #BiotechInnovation #LaserForceCytology #RadiancePlatform #Biomanufacturing #CellAnalysis #InnovationInBiotech biotechtv.com/post/lumacyte-…

Join LumaCyte's President and CBO Renee Hart at the 6th Annual Cell Therapy Analytical Development Summit. She will join Ramon Mendoza, Alexandre Ambrogelly, and Stephan Krause for the Industry Leaders’ Fireside Chat: Pioneering Analytical Frontiers to Overcome the Complexities of Cell Therapy Products – Insights from Cell Therapy’s Foremost Analytical Minds at 8:40 am on Wednesday, December 4. Don’t miss out on this exciting Cell Therapy Analytical Development event! #CellTherapy #AnalyticalDevelopment #Biotech #Innovation #Healthcare #RegulatoryAffairs #MedicalResearch #LifeSciences

We are excited to announce that Colin Hebert, Senior Vice President of Scientific & Business Operations at LumaCyte, will be presenting at the 6th Annual Cell Therapy Analytical Development Summit on Wednesday, December 4, 2024. Don't miss his presentation at 12:30 pm titled "Quantitative Cell Characterization Using Laser Force Cytology™ (LFC): Predictive Insights into CAR T Donor Variability." Discover how our label-free, quantitative precision PAT technology, Laser Force Cytology™, provides real-time insights into cellular changes and ensures robust cellular fitness. Gain valuable knowledge on the correlation of CAR T potency with donor cellular starting material and T-cell activation road mapping. Exciting new data and insights await! lumacyte.com/schedule-a-mee… #CellTherapy #AnalyticalDevelopment #LaserForceCytology #CAR_T #Biopharma #LumaCyte #InnovativeTech #CellAnalysis